Skip to content

Psilocybin for anxiety: all studies

Page 19 of 31: studies 181 to 190 of 305, newest first. Back to the psilocybin for anxiety overview

Research

Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon

Cureus May 23, 2022 Kawther N Elsouri, Sahand Kalhori, Diego Colunge et al. 15 citations

Post-traumatic stress disorder (PTSD) is an anxiety disorder that often presents after exposure to a traumatic, life-threatening event. Experiencing a traumatic event is not rare, with inciting incidents ranging from being burglarized to politically motivated genocide. While traditional psychopharmacology and psychotherapy are the mainstays of the treatment of PTSD currently, psychoactive drugs...

New Paradigms of Old Psychedelics in Schizophrenia

Pharmaceuticals May 23, 2022 Danish Mahmood, Sattam Khulaif Alenezi, Md Jamir Anwar et al. 29 citations

Psychedelics such as lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), and mescaline exhibit intense effects on the human brain and behaviour. In recent years, there has been a surge in studies investigating these drugs because clinical studies have shown that these once banned drugs are well tolerated and efficacious in medically supervised low doses called microdosing....

The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-Analysis

Current Psychiatry Research and Reviews May 16, 2022 Andrew Hodge, Suporn Sukpraprut‐braaten, Robert Strayhan 4 citations

Background: The use of psychedelic compounds to treat psychiatric disorders has become a very significant topic of research over the past several years. Psilocybin has risen to prominence as one of the most studied among these psychedelic compounds. Multiple trials have already shown that it can be a safe and efficacious treatment for various medical conditions. This study intends to perform a...

Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges

Expert Opinion on Drug Safety April 15, 2022 Giordano Novak Rossi, Jaime E. C. Hallak, José Carlos Bouso Saiz et al. 24 citations

There were no serious AEs related to psilocybin and LSD administration. Most AEs were expected, manageable, and transient. Nevertheless, safety and tolerability concerns regarding some effects, such as dissociation, paranoia, and confusion, remain. Thus, randomized controlled trials with bigger samples are warranted to confirm their therapeutic effects and further investigate their safety and...

Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders

Molecules April 13, 2022 Henry Lowe, Ngeh J. Toyang, Blair Steele et al. 53 citations

The word “psychedelic” (psyche (i.e., the mind or soul) and delos (i.e., to show)) has Greek origin and was first coined by psychiatrist Humphry Osmond in 1956, who had been conducting research on lysergic acid diethylamide (LSD) at the time. Psychedelic drugs such as N,N-DMT/DMT (N,N-dimethyltryptamine), 5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine), LSD (lysergic acid diethylamide), MDMA...

The Therapeutic Efficacy of Psilocybin in a Preclinical Model of Depressive- and Anxiety-Like Symptomology

April 12, 2022 Henry Chafee

<p><b>Depressive and anxiety disorders are debilitating psychiatric illnesses that affect a substantial portion of the world population. Current pharmaceutical interventions, such as selective serotonin reuptake inhibitors, are generally regarded as front-line treatments but are not universally effective at reducing symptomology. Psilocybin, the active component in Psilocybe cubensis mushrooms,...

Cannabis Culture and Spirituality

Cambridge University Press eBooks March 20, 2022 Timmen Cermak

Jackson was bored with his massage therapy practice and was looking for something more interesting to do. Cannabis legalization had reawakened his interest in the use of natural, psychoactive substances as healing and spiritual agents. A once-a-month user of cannabis, he was enthusiastic about Johns Hopkins University’s research on the potential mental health benefits of psilocybin, the...

A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders

Australian & New Zealand Journal of Psychiatry March 12, 2022 Steve Kisely, Mark Connor, Andrew A Somogyi et al. 36 citations

Objectives: There is an increasing interest in combining psilocybin or methylenedioxymethamphetamine with psychological support in treating psychiatric disorders. Although there have been several recent systematic reviews, study and participant numbers have been limited, and the field is rapidly evolving with the publication of more studies. We therefore conducted a systematic review of PubMed,...

Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain

Journal of Fungi March 11, 2022 Elaine Meade, Sarah Hehir, Neil J. Rowan et al. 24 citations

Mushrooms have been used as traditional medicine for millennia, fungi are the main natural source of psychedelic compounds. There is now increasing interest in using fungal active compounds such as psychedelics for alleviating symptoms of mental health disorders including major depressive disorder, anxiety, and addiction. The anxiolytic, antidepressant and anti-addictive effect of these...